JEFF BEHRENS, MS, MBA – PRESIDENT AND CEO, BOARD MEMBER
Jeff joined Siamab Therapeutics in May 2012. From 2009 to 2012, he served as Senior Director of Business Development & Operations for Edimer Pharmaceuticals, a Third Rock-funded orphan drug company, where he oversaw manufacturing, finance, business development, and academic research collaborations. Prior to Edimer, Jeff worked at Alnylam as Director, Strategic Alliances and at Biogen Idec as co-founder and Head of Business Operations at the Biogen Idec Innovation Incubator. Jeff has an MBA from MIT Sloan and a MS from the joint Harvard/MIT Division of Health Sciences and Technology. Jeff was previously the founder and CEO of The Telluride Group, a Newton, MA based managed services IT provider to the healthcare industry that was sold to mindSHIFT Technologies (funded by Fidelity) in 2003.
BRAD CURLEY, BS, CPA - BOARD CHAIR
Brad Curley is a member of Boston Harbor Angels and an adjunct professor at Boston College. He was with KPMG LLP for more than 25 years providing services to clients in many industries. Brad was Partner in Charge of KPMG’s New England Area Internal Audit, Risk and Compliance Services practice and also served as the Firm’s Advisory Services practice leader for Northeast Area middle market accounts. He is a member of Board Leaders, the Corporate Directors Group and the National Association of Corporate Directors.
PETER KROON, MBA - BOARD MEMBER
Peter Kroon was appointed to the Board of Directors at Siamab in 2015. He is Chairman of Twin Oaks Software Development, Inc., which he co-founded in 1992. He was also the co-founder of Healthtrax Properties, Inc. Peter is a serial entrepreneur and an active angel investor in the Boston area. He has an MBA from Harvard Business School.
GARY PFORZHEIMER, MBA - BOARD MEMBER
Gary Pforzheimer was appointed to the Board of Directors at Siamab in 2016. He is President of PG Clac, which he founded in 1985. He received an AB in History from Harvard College and an MBA from Harvard Business School.